OPG could regulate the activity of the MAPK signaling pathway via DUSP14, thus regulating the expression of some inflammatory factors in NASH, it may be a promising target for the treatment of NASH. This evidence concerns the gene DUSP14 and metabolic dysfunction-associated steatohepatitis.